A therapeutic apparatus for therapeutic ultrasonic treatment of a tissue region that contains a flowing liquid has at least one ultrasonic source and a control unit for activating the ultrasonic source in order to radiate ultrasonic pulses according to a pulse parameter set into the tissue region. The therapeutic apparatus has a measuring system configured to determine a flow velocity of the liquid and a focus control system configured to move a focus region of the ultrasonic pulse relative to the tissue region over a longitudinal portion. A movement direction of the focus region therein corresponds to a flow direction of the liquid and a movement velocity of the focus region corresponds to the flow velocity.

A method of manufacturing a lead. The method includes providing a supporting tube, and disposing a conductive strip on an outer surface of the supporting tube such that the conductive strip extends in an axial direction along a length of the supporting tube. The method also includes mounting a chip having a first conductive contact pad and a second conductive contact pad to the supporting tube such that the first conductive contact pad is in contact with the conductive strip. The method further includes fitting an electrode to the supporting tube such that the electrode is in contact with the second conductive contact pad, and coupling a conductor to each end of the supporting tube such that each conductor is in contact with the conductive strip. The method also includes covering at least one of the chip and the conductors with a sheath to provide the lead.

An ultrasound diagnosis apparatus according to an embodiment includes processing circuitry. The processing circuitry is configured to speculate saturation of reflected-wave signals observed before a phased addition process performed by using the reflected-wave signals, in accordance with an intensity of reflected-wave data generated through the phased addition process, the reflected-wave signals being generated by transmitting an ultrasound wave with respect to mutually the same scanning line, and the processing circuitry is configured to output a result of the speculation. The processing circuitry is configured to cause a display to display data based on the result of the speculation.

An ultrasound diagnosis apparatus according to an embodiment includes processing circuitry. The processing circuitry is configured to speculate saturation of reflected-wave signals observed before a phased addition process performed by using the reflected-wave signals, in accordance with an intensity of reflected-wave data generated through the phased addition process, the reflected-wave signals being generated by transmitting an ultrasound wave with respect to mutually the same scanning line, and the processing circuitry is configured to output a result of the speculation. The processing circuitry is configured to cause a display to display data based on the result of the speculation.

A transducer fixation apparatus is configured to position and secure to a skin surface of a patient a transducer to allow repeated or continuous monitoring of blood flow in a subsurface vessel. The transducer fixation apparatus includes a housing having a plurality of flexible attachment wings that attach and conform in shape to the skin surface using an adhesive material present on each of the wing undersides. In some embodiments the wings may be biased upward away from the skin surface to facilitate positioning of the fixation apparatus prior to skin attachment. Alternative embodiments include a detachable retainer clip to hold the wings away from the mounting surface during placement as well as an optional positioning wand to aid with placement. Other embodiments may include a separate flexible attachment wing configured to hold a gel pad for acoustic coupling to the skin surface, the separate flexible attachment wing intended to be joined to the housing of the transducer fixation apparatus prior to skin surface attachment.

A transducer fixation apparatus is configured to position and secure to a skin surface of a patient a transducer to allow repeated or continuous monitoring of blood flow in a subsurface vessel. The transducer fixation apparatus includes a housing having a plurality of flexible attachment wings that attach and conform in shape to the skin surface using an adhesive material present on each of the wing undersides. In some embodiments the wings may be biased upward away from the skin surface to facilitate positioning of the fixation apparatus prior to skin attachment. Alternative embodiments include a detachable retainer clip to hold the wings away from the mounting surface during placement as well as an optional positioning wand to aid with placement. Other embodiments may include a separate flexible attachment wing configured to hold a gel pad for acoustic coupling to the skin surface, the separate flexible attachment wing intended to be joined to the housing of the transducer fixation apparatus prior to skin surface attachment.

A multifunctional probe includes a hand-held housing, a signal detector and an array probe. The signal detector is flexibly disposed on the hand-held housing or at its first end. The array probe is disposed at one end (e.g., second end) of the hand-held housing and electrically coupled to the signal detector. The first contact time of the signal detector in contact with the living body may at least partially overlap with the second contact time of the array probe in contact with the living body. The signal detector and the array probe generate the first electronic signal. The multifunctional probe includes a flexibly-connected signal detector and an array probe, which can contact and/or detect the living body at the same time. Thus, the detection efficiency and accuracy are effectively increased. A detection method applied to the multifunctional probe is also provided.

A multifunctional probe includes a hand-held housing, a signal detector and an array probe. The signal detector is flexibly disposed on the hand-held housing or at its first end. The array probe is disposed at one end (e.g., second end) of the hand-held housing and electrically coupled to the signal detector. The first contact time of the signal detector in contact with the living body may at least partially overlap with the second contact time of the array probe in contact with the living body. The signal detector and the array probe generate the first electronic signal. The multifunctional probe includes a flexibly-connected signal detector and an array probe, which can contact and/or detect the living body at the same time. Thus, the detection efficiency and accuracy are effectively increased. A detection method applied to the multifunctional probe is also provided.

Systems, methods, and instrumentalities are disclosed for switching a control scheme to control a set of system modules and/or modular devices of a surgical hub. A surgical hub may determine a first control scheme that is configured to control a set of system modules and/or modular devices. The surgical hub may receive an input from one of the set of modules or a device located in an OR. The surgical hub may make a determination that at least one of a safety status level or an overload status level of the surgical hub is higher than its threshold value. Based on at least the received input and the determination, the surgical hub may determine a second control scheme to be used to control the set of system modules. The surgical hub may send a control program indicating the second control scheme to one or more system modules and/or modular devices.

The disclosure provides wearable cardiac arrest detection and alerting device that incorporates a non-invasive sensor based on optical and/or electrical signals transmitted into and received from human tissue containing blood vessels, and that transcutaneously quantifies the wearer's heart rate. The heart-rate quantification enables the detection of the absence of any heart beat by the wearable detection and alerting device indicative of the occurrence of a cardiac arrest, wherein the heart is no longer achieving effective blood circulation in the individual wearing the device. The display on the wearable cardiac arrest detection and alerting device may include the elapsed time since the time of detection of a heart rate that is below a predetermine lower limit value, i.e., the detected occurrence of a cardiac arrest event.